| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04ca390052b363bf3f6c288d9ed7fc1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_737f7c6979b9f72e1970146f21e6360e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ba9d3c51f2379d0ef4c80396ed6242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd72b62392a47f977d2504df183be6be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b93c2812fec3aff1cdd198644593329 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate |
2012-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ea67eb4eefd7f622ac2514adce3254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68afff52bcac5b54658cf256914fe1bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_836f638744908451bdf7eef01870b917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8151a661f0430b8690f023682cad64e |
| publicationDate |
2013-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013003001-A1 |
| titleOfInvention |
Process for preparing heparinoids and intermediates useful in the synthesis thereof |
| abstract |
Processes are disclosed for the synthesis of the Factor Xa anticoagulant fondaparinux and related compounds. Protected pentasaccharide intermediates and efficient and scalable processes for the industrial scale production of fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105473602-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103601766-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103601766-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109096348-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108148101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108148101-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105001278-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109096348-A |
| priorityDate |
2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |